HIV disproportionately affects members of the LGBTQ+ communities of color, particularly cisgender Black and Latino gay and bisexual, transgender women, and Black women. We are committed to ending the HIV epidemic and HIV-related stigma.
Choose from one of our featured topics to explore specific areas of our HIV & Health Equity resources.
Making HIV History + A Pragmatic Guide to Confronting HIV at Historically Black Colleges and Universities is a comprehensive guide for HBCU administrators, staff and students outlining many of the…
A pesar de varios años de investigaciones acerca del VIH/SIDA y las poblaciones que afecta, sabemos muy poco sobre las personas transgénero y el VIH.
PrEP is short for Pre-Exposure Prophylaxis, a once-daily pill that reduces the risk of acquiring HIV. It is an FDA-approved prescription medication.
PEP is short for Post-Exposure Prophylaxis. It is an HIV prevention strategy that involves taking HIV medications immediately after a single high-risk event.
The Interfaith Health Equity Alliance Roundtable (IHEAR) was created to convene faith leaders that are committed to ending HIV stigma and discrimination in their communities. We aim to expand and…
This guide is meant to be a starting point for reporters, journalists, bloggers, and community advocates interested in covering the the HIV epidemic both accurately and compassionately.
HRC is proud to partner with The PRIDE Study - the first nationwide, large-scale, long-term health study of people who identify as lesbian, gay, bisexual, transgender, queer (LGBTQ+), or another…
While HIV affects Americans from all walks of life, the epidemic continues to disproportionately impact certain members of the LGBTQ+ community.
Here are some things you can do before, during, and after your first visit to discuss PrEP.
Americans living with HIV or AIDS may face discrimination based on their health status in many areas of life—including employment. Fortunately, federal and state laws protect against discrimination.
